{"id":187051,"date":"2024-04-09T12:23:21","date_gmt":"2024-04-09T17:23:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/04\/exclusive-synchron-a-rival-to-musks-neuralink-readies-large-scale-brain-implant-trial"},"modified":"2024-04-09T12:23:21","modified_gmt":"2024-04-09T17:23:21","slug":"exclusive-synchron-a-rival-to-musks-neuralink-readies-large-scale-brain-implant-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/04\/exclusive-synchron-a-rival-to-musks-neuralink-readies-large-scale-brain-implant-trial","title":{"rendered":"Exclusive: Synchron, a rival to Musk\u2019s Neuralink, readies large-scale brain implant trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/exclusive-synchron-a-rival-to-musks-neuralink-readies-large-scale-brain-implant-trial2.jpg\"><\/a><\/p>\n<p>Synchron on Monday plans to launch an online\u2026<\/p>\n<hr>\n<p>WASHINGTON, April 8 (Reuters) \u2014 Synchron Inc, a rival to Elon Musk\u2019s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company\u2019s chief executive told Reuters.<\/p>\n<p>Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an interview.<\/p>\n<p>\u201cPart of this registry is to start to enable local physicians to speak to patients with motor impairment,\u201d he said. \u201cThere\u2019s a lot of interest so we don\u2019t want it to come in a big bottleneck right before the study we\u2019ll be doing.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Synchron on Monday plans to launch an online\u2026 WASHINGTON, April 8 (Reuters) \u2014 Synchron Inc, a rival to Elon Musk\u2019s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company\u2019s chief executive told Reuters. Synchron on Monday plans to launch an [\u2026]<\/p>\n","protected":false},"author":705,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,2019,47],"tags":[],"class_list":["post-187051","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-elon-musk","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/187051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/705"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=187051"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/187051\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=187051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=187051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=187051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}